Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity

DOI PDF PDF 被引用文献11件
  • Erin E. Kershaw
    Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
  • Nicholas M. Morton
    Endocrinology Unit, Molecular Medicine Center, University of Edinburgh, Western General Hospital, Edinburgh, U.K
  • Harveen Dhillon
    Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
  • Lynne Ramage
    Endocrinology Unit, Molecular Medicine Center, University of Edinburgh, Western General Hospital, Edinburgh, U.K
  • Jonathan R. Seckl
    Endocrinology Unit, Molecular Medicine Center, University of Edinburgh, Western General Hospital, Edinburgh, U.K
  • Jeffrey S. Flier
    Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

抄録

<jats:p>Local glucocorticoid (GC) action depends on intracellular GC metabolism by 11β-hydroxysteroid dehydrogenases (11βHSDs). 11βHSD1 activates GCs, while 11βHSD2 inactivates GCs. Adipocyte-specific amplification of GCs through transgenic overexpression of 11βHSD1 produces visceral obesity and the metabolic syndrome in mice. To determine whether adipocyte-specific inactivation of GCs protects against this phenotype, we created a transgenic model in which human 11βHSD2 is expressed under the control of the murine adipocyte fatty acid binding protein (aP2) promoter (aP2-h11βHSD2). Transgenic mice have increased 11βHSD2 expression and activity exclusively in adipose tissue, with the highest levels in subcutaneous adipose tissue, while systemic indexes of GC exposure are unchanged. Transgenic mice resist weight gain on high-fat diet due to reduced fat mass accumulation. This improved energy balance is associated with decreased food intake, increased energy expenditure, and improved glucose tolerance and insulin sensitivity. Adipose tissue gene expression in transgenic mice is characterized by decreased expression of leptin and resistin and increased expression of adiponectin, peroxisome proliferator–activated receptor γ, and uncoupling protein 2. These data suggest that reduction of active GCs exclusively in adipose tissue is an important determinant of a favorable metabolic phenotype with respect to energy homeostasis and the metabolic syndrome.</jats:p>

収録刊行物

  • Diabetes

    Diabetes 54 (4), 1023-1031, 2005-04-01

    American Diabetes Association

被引用文献 (11)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ